0000920465-19-000032.txt : 20190213
0000920465-19-000032.hdr.sgml : 20190213
20190213182524
ACCESSION NUMBER: 0000920465-19-000032
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20190213
DATE AS OF CHANGE: 20190213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 19599456
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
5
1
wf-form5_155010030902407.xml
FORM 5
X0306
5
2018-12-31
0
0
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
1
1
0
0
President, CEO & Secretary
Common Stock
2018-06-08
5
G
0
17742
0
D
1266704
D
Common Stock
2018-06-08
5
G
0
900
0
D
1265804
D
Common Stock
2018-06-08
5
G
0
900
0
D
1264904
D
Common Stock
2018-06-08
5
G
0
900
0
D
1264004
D
Common Stock
2018-06-08
5
G
0
900
0
D
1263104
D
Common Stock
22000
I
By children
/s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh
2019-02-13